| 前收市價 | 220.31 |
| 開市 | 218.68 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 218.11 - 221.66 |
| 52 週波幅 | 154.10 - 227.22 |
| 成交量 | |
| 平均成交量 | 7,518 |
| 市值 | 628.098M |
| Beta 值 (5 年，每月) | 1.10 |
| 市盈率 (最近 12 個月) | 0.58 |
| 每股盈利 (最近 12 個月) | 3.84 |
| 業績公佈日 | 2024年4月30日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksDexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
DexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
ZacksRevvity's (RVTY) New Launch to Boost Tuberculosis Testing
Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
ZacksCONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
